A Study to Evaluate the Safety and Efficacy of Rituximab in Adults With Primary Progressive Multiple Sclerosis
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a Phase II/III, randomized, double-blind, parallel group, placebo controlled,
multicenter study to evaluate the safety and efficacy of rituximab in adults with PPMS. The
study will enroll approximately 435 subjects at up to 60 sites in the United States and
Canada.